Inducted in 2026
Mr. Beachell is one of the founding partners of Veritable LP, an investment advisory firm founded in 2004. Mr. Beachell served on the firm's Executive, Investment and Operations Committees, and led a six-person investment team. In 2023, Veritable LP was acquired by partner-owned advisory firm Pathstone; Mr. Beachell stayed on as a managing director and shareholder, working with boards, CIOs and trustees to design governance, investment policy and implementation plans that align incentives and withstand stress. Previously, Mr. Beachell was a senior portfolio manager & manager, operations at Hawthorn, formed by the acquisition of Stolper & Co. in 1997. Prior to Hawthorn, he was a portfolio manager, fixed income portfolio manager & IT director at Stolper & Co. from 1993 to 1997.
Mr. Beachell is a member of the Honickman Foundation Advisory Board. He is a former board member of the Lenfest Foundation and chaired its Finance Committee. Prior to graduating magna cum laude with a bachelor's degree in economics from Drexel University, Mr. Beachell also studied at the University of Oxford.
As a Drexel alumnus, Mr. Beachell has generously supported the University. He previously served on the Drexel University Board of Trustees, the Academy of Natural Sciences Board of Trustees, the LeBow College of Business Economics Advisory Board and the President's Leadership Council. The Beachell Family Learning Center, located in the Dornsife Center for Neighborhood Partnerships, is named in honor of Mr. Beachell and his family. In 2016, Mr. Beachell was nominated by Drexel and named to the World Association of Cooperative Education Hall of Fame, and in 2018, he received the Drexel Silver Dragon Award. His daughter, Riley, is a current student at Drexel.
Mr. Berk is Partner and Head of Technology at Brown Brothers Harriman (BBH), a privately owned and managed financial services firm that is organized as a private partnership and includes private banking, investor services & markets, and investment management businesses.
Mr. Berk joined BBH in 1995, became CIO in 2000 and Head of the Systems Division and Partner in 2005. He served as CIO until 2010. Under his leadership as CIO, BBH delivered countless technology applications. In addition, Mr. Berk has had responsibility for the complex behind-the-scenes infrastructure required by BBH to support mission critical functions, such as data security, data privacy and Anti-Money-Laundering/Know Your Customer compliance.
Mr. Berk has served as a trustee at South Shore Health System Foundation in Weymouth, Massachusetts and as a trustee for the American Red Cross in Greater New York. Mr. Berk was elected to Drexel's Board of Trustees in 2019 and serves as Chair of the Audit Committee and as a member of the Academic Affairs Committee, Finance and Human Resources Committee, and Executive Committee. In 2018, Mr. Berk joined the College of Computing & Informatics (CCI) Dean’s Advisory Council. Also in 2018, Mr. Berk was the CCI commencement speaker. In 2017, he and his wife Christine established the Rick and Christine Berk Scholarship Fund for Women in Computing, which is used for students in the College of Computing & Informatics. Mr. Berk remains involved with his fraternity, Pi Kappa Phi.
A catalyst in Philadelphia’s arts and culture community, Ms. Cahill brought leadership experience from major arts organizations in New York, Toronto and Chicago to Highmark Mann Center for the Performing Arts when she became President & CEO in 2008. Since then, she has transformed Highmark Mann’s business model, reimagined the audience experience, integrated new stages and festivals, strengthened Highmark Mann's Fairmount Park campus in the cultural marketplace, and expanded community impact through comprehensive education and engagement initiatives serving young people.
During her tenure at Highmark Mann, Ms. Cahill has overseen three major capital campaigns, established long-term partnerships with promoters including Live Nation Entertainment and previously AEG/Bowery Presents to diversify contemporary programming and host major touring artists, blended genres to create culturally relevant programming for diverse audiences, commissioned new world-premiere works, and launched signature initiatives including Movies @ the Mann and Downstage @ the Mann. She also commissioned a multi-pronged education and community engagement strategy addressing out-of-school time, workforce development and creative placemaking to better serve the Parkside neighborhood and the city of Philadelphia.
Prior to Highmark Mann, Ms. Cahill served as CEO of the Brooklyn Philharmonic, Executive Director of the Toronto Symphony Orchestra, General Manager of the New York Philharmonic, and Festival & Artistic Director of Chicago’s Grant Park Music Festival. A trained cellist, she earned a Bachelor of Music from Temple University and a Master of Science in Arts Administration/Arts Management from Drexel University. She began her career as a management fellow with the American Symphony Orchestra League, working with orchestras nationwide.
Ms. Connors worked for 30 years as a corporate finance specialist supporting technology, global sales, marketing, manufacturing and R&D units of major corporations, including WR Grace, Gillette, Digital Equipment Corporation and Compaq Computer. Her work included budgeting, financial analysis, capital investments, cost reduction and M&A. She retired from Fidelity Investments as Vice President of Finance.
In addition to her Drexel degree, she has an MBA in Finance and International Business from The Wharton School, University of Pennsylvania, and served as President and Chairman of the Wharton Graduate Alumni Association.
Her community involvement through the years includes numerous leadership roles, committee chairmanships and treasurer positions in local and national nonprofit organizations in areas of health care, the arts and education, and cultural and historical groups. For many years, she was honored as a top fundraiser for the Leukemia & Lymphoma Society. She has endowed Work Force, a community-based nonprofit dedicated to ending the cycle of generational poverty and getting young people out of public housing and on their own through education, mentoring and social networking.
Ms. Cooper ’68 and her father William '67 are the first members of their family to graduate from college. In 2012, she established the Agnes and William Connors Endowed Scholarship Fund which funds tuition for students in Business and Engineering at the Bennett S. LeBow College of Business. Hers is one of the largest individual donations for Drexel student scholarships.
Dr. Cooper, now retired, is Professor of Anaesthesia, Emeritus, at Harvard Medical School and Massachusetts General Hospital. He is the founder, Executive Director Emeritus and Senior Fellow of the Center for Medical Simulation, which is dedicated to the use of simulation in healthcare to improve the process of education and training and to avoid risk to patients.
Dr. Cooper is one of the pioneers in what is now called patient safety. He did landmark research in medical errors in the 1970s and is a co-founder of the Anesthesia Patient Safety Foundation (APSF). He was for many years Director of Biomedical Engineering at the Massachusetts General Hospital and then Partners Healthcare System. He is author or co-author of over 150 peer-reviewed articles and book chapters. He is still active on several research projects and as a mentor and advisor.
Dr. Cooper has been awarded several honors for his work in patient safety, simulation and clinical engineering, including the John M. Eisenberg Award for Lifetime Achievement in Patient Safety from the National Quality Forum and the Joint Commission and the Lifetime Achievement Award from the American Academy of Clinical Engineering. He received the Distinguished Service Award of the American Society of Anesthesiologists in 2013, the only non-MD to receive the honor. He is one of the first two members of the Hall of Fame of the American College of Clinical Engineering. The Society for Simulation in Healthcare recently honored him with its Pioneer Award.
A real life “Guardian of the Galaxy,” Dr. Cooper holds the responsibility of keeping the red planet safe from the Earth’s contaminants. Dr. Cooper is a planetary protection lead of the famed NASA 2020 Mars mission and Supervisor of the Induced Environments Group at the Jet Propulsion Laboratory in Pasadena, California. She leads interdisciplinary teams developing contamination-control strategies, metagenomics standards, DNA-based detection tools, and AI-enabled risk-assessment models that safeguard spacecraft and enable safe exploration of Mars, Europa and beyond.
After graduating from high school at 16, Dr. Cooper studied physics as an undergraduate at Hampton University, with a minor in space, earth, and atmospheric sciences. She went on to receive a master’s degree and earn her PhD in mechanical engineering from Drexel University at 24 years old with a dissertation on sterilizing spacecraft materials from extremophile microorganisms. At JPL, her work contributed to the Curiosity Rover, Insight Lander, Mars 2020 Rover, Ingenuity Mars Helicopter and more.
In her role, Dr. Cooper is a recipient of several awards, including the NASA Early Career Public Achievement Medal, the Charles Elachi Award for Exceptional Early Career Achievement and JPL Voyager Awards for Technical Leadership.
In addition to her technical expertise, Dr. Cooper is passionate about mentoring aspiring scientists and engineers, striving to inspire the next generation of space explorers and innovators. Outside of her work in the space industry, Dr. Cooper enjoys media appearances and public outreach efforts, as she seeks to share her love of science and space exploration with audiences around the world.
Mr. Gillespie is a global executive, dedicated community leader and advocate for expanding opportunity for young people.
Mr. Gillespie currently serves as Senior Vice President, U.S. Oncology Therapeutic Area Head at Novartis Pharmaceuticals, where he leads a multibillion-dollar oncology portfolio. His career includes senior leadership roles at Janssen Oncology and AstraZeneca, with experience spanning the United States, United Kingdom and South Africa, including serving as Country President for AstraZeneca South Africa.
Mr. Gillespie has served on several nonprofit and educational boards, including the American International School of South Africa, and remains actively involved in mentoring students and early-career professionals, including those from his alma mater, Drexel University. He currently holds leadership roles with Alpha Phi Alpha Fraternity, Inc. and Sigma Pi Phi and serves on the board of YALA of the Los Angeles area and Summer Search of Philadelphia.
Mr. Gillespie holds a Bachelor of Science in Commerce & Engineering from Drexel University and an MBA from the University of Washington.
Mr. Gillespie lives in Chadds Ford, Pennsylvania, with his wife, Angela, and has two daughters, Jasmyn and Jaida. Jasmyn is building her career in the biotech industry and Jaida is a recent graduate of Howard University pursuing a career in theater. Mr. Gillespie enjoys staying active, reading, listening to podcasts, traveling, and cheering on the Philadelphia Eagles and New York Knicks.
Dr. Jamerson's career, to date, has been focused on service and science leadership. Following the completion of his PhD in Biology from Georgetown University, Dr. Jamerson joined the U.S. Navy's Medical Service Corps as a biochemist/toxicologist.
While in the Navy, Dr. Jamerson served in multiple leadership roles focused on warfighter health, safety and readiness. As Drug Testing Program Manager for the Department of the Navy, he led a zero-tolerance-for-error forensic drug testing program for Sailors and Marines worldwide, processing approximately 2.5 million specimens per year. As Commanding Officer of the Naval Submarine Medical Research Laboratory and Executive Officer of the Naval Health Research Center, he has led teams ranging from 90 to more than 400 people in executing human performance, health and epidemiological research efforts on behalf of submariners, divers, Sailors and Marines. He also led teams testing specimens in support of drug demand efforts as Commanding Officer & Executive Officer of the Navy Drug Screening Laboratory in San Diego and Executive Officer of the Navy Drug Screening Laboratory in Jacksonville.
In November 2025, following 22 years of service, Dr. Jamerson retired from the Navy as a Captain. Immediately, Dr. Jamerson sought out a new avenue for service — volunteering as a Reserve police officer with his community's department. Presently, Dr. Jamerson continues to inspect forensic toxicology laboratories nationwide while he prepares to start a second career as an expert scientific consultant.
Dr. Kramer is the Vice President of the Cross Therapeutic Area Delivery Unit at Johnson & Johnson. Over more than two and a half decades with the company, she has led clinical development programs across Phases 1–4. Her experience spans a wide range of therapeutic areas, including neuroscience, immunology, infectious disease, oncology, and cardiovascular and metabolic diseases.
In her current role, Dr. Kramer oversees the delivery of global clinical studies for both rare and prevalent conditions. She integrates scientific and medical strategies with operational excellence to help address unmet health needs in communities worldwide.
Her work has involved research around the world, including having led a team in Japan and participating in the Asia Pacific Economic Cooperation (APEC) Mental Health Initiative for several years. She is also a member of the J&J Bioethics Committee and active in several mentoring initiatives for employees and interns interested in STEM careers.
She earned her bachelor's degree in psychology from the University of Colorado Boulder, her medical degree from Tufts University School of Medicine, and completed her psychiatry residency and psychopharmacology fellowship at Duke University. She completed her Master of Public Health at Drexel early in her career while working at J&J. As a Drexel alumna, she participated as a panelist for the “Experts to Discuss Health Equity” session at the 2024 Arts and Sciences Symposium hosted by Drexel University.
Dr. Kramer lives in the Philadelphia area with her husband, also a Drexel graduate.
Dr. Langell has more than 30 years of experience in academic medicine and higher education and is a nationally recognized leader in health care innovation, operations and strategy. He has held senior leadership roles — including president, commander (CEO), surgical section chief, clinical program manager, and chief of general surgery — across academic health systems, VA-affiliated programs, and U.S. Air Force medical facilities. His career spans clinical excellence, academic leadership and entrepreneurship, with recognition from The Wall Street Journal, Becker’s Healthcare, Fast Company, the American Medical Association, the Association for Academic Surgery, the World Health Organization and NASA. He completed his surgical residency at Stanford University and advanced training in space medicine at Johnson Space Center. He is board-certified in general surgery and a fellow of the American College of Surgeons.
As president of Northeast Ohio Medical University, he has led an institutional transformation focused on growth, innovation and sustainability — expanding from a single campus to a statewide enterprise, increasing enrollment by more than 200%, doubling revenues and tripling reserves. Under his leadership, NEOMED launched a College of Dentistry and seven research institutes, earned U.S. News & World Report Best Graduate School recognition and Carnegie Research designation.
Previously Vice Dean for Innovation at the University of Utah, he built a leading medical innovation ecosystem — generating more than 180 technologies, launching over 50 startups and filing more than 110 patents. A Lean Six Sigma Black Belt and retired U.S. Air Force Colonel, he completed a 24-year military career, including service as a medical commander overseeing multidisciplinary organizations.
Dr. Lee is the Administrator for the Department of Emergency Medicine at Jefferson Einstein Hospitals, where she provides leadership for two emergency departments serving more than 120,000 patients annually. Her portfolio includes strategic planning, program development, business operations, oversight of EMS contracts, ultrasound sonography, toxicology services, clinical research and medical education programs.
Her professional path includes early roles in engineering and academic administration; however, it is in healthcare management where she found her meaningful work. Dr. Lee has held leadership roles across diverse healthcare settings, including primary and specialty care, community health centers, academic hospital-based ambulatory sites and private practices. Throughout her career, she has led initiatives implementing systems and processes to optimize operational efficiency, strengthen financial performance and support population health management — advancing patient-centered care, reducing cost of care and improving health outcomes.
Dr. Lee’s research focuses on medically underserved populations and the challenges they face in accessing quality healthcare and managing their own health. She has co-authored two research publications with Dr. David Gefen, Academic Director of the Executive Doctorate of Business Administration program, examining adoption of patient healthcare portals and telemedicine among underserved and minority populations. Her work includes a book chapter on patient portals and a peer-reviewed study in ACM SIGMIS Database exploring how trust and subjective norms influence telemedicine adoption among patients at Jefferson Einstein Hospital Philadelphia.
A proud “Triple Dragon,” Dr. Lee holds a Doctorate in Business Administration, an MBA in Marketing, and a Bachelor of Science in Chemical Engineering from Drexel University.
Mr. Lemmo is Vice President and General Manager of Lockheed Martin’s Sensors, Effectors & Mission Systems line of business. He directs the strategic, operational and financial performance of a diversified portfolio that includes radar, electronic-warfare, acoustic and laser weapons, counter-UAS solutions, airborne and maritime mission systems, launch systems, and uncrewed vessels.
With 40 years of defense-industry leadership, Mr. Lemmo has held progressively senior roles spanning P&L responsibility, general management, business development, engineering and program management. Most recently, as President of Sikorsky, he oversaw government and commercial rotorcraft development and manufacturing for the U.S. Armed Forces and global customers. Earlier, as Lockheed Martin's Senior Vice President of Corporate Strategy and Business Development he was responsible for global strategies, new business capture and leading the worldwide strategy and business development organization.
He also served eight years on the Lockheed Martin Ventures Investment Committee. Mr. Lemmo sits on the Board of Directors for the Chamber of Commerce for Greater Philadelphia, is a member of Drexel University's President's Leadership Council, and serves on the University of Connecticut Board of Advisors.
He earned a Bachelor of Science and Master of Science in Electrical Engineering (summa cum laude) from Drexel University, an MBA from The Wharton School, and an honorary Doctor of Engineering from the University of New Haven.
Ms. Lockhart is the founder of the Global Give Back Circle, of one of Kenya’s largest mentorship, economic empowerment and workforce-readiness programs for at-risk women and girls. She believes partnerships drive scalable and sustainable impact. In addition to her partnership model with high schools for girls in Kenya, Ms. Lockhart created the HER Lab model, a skills-building educational campus, as a solution for the unique workforce-readiness needs of rural women and girls who have been marginalized through harmful cultural practices. Drexel University’s Charles D. Close School of Entrepreneurship delivers the entrepreneurship curriculum via Zoom to participants. Mastercard Foundation is partnering in the scale-up of the HER Lab model across Kenya, and Suze Orman is partnering in the scale-up of the HER Financial Freedom Program, a woman-owned credit union for thousands of rural women.
Ms. Lockhart is a Forbes 50 Over 50 honoree — a serial social entrepreneur dedicated to gender equity. Earning a Bachelor of Science in Fashion Design from Drexel University taught her how to think creatively and simplify complexity. Five years at Bloomingdale’s taught her how to run a business. An MBA from Cornell University’s Johnson School of Management led her to retail banking at a time when banks wanted customer-centric retail thinking. After amplifying her retail banking customer experience expertise through print, media and conference engagements globally, Ms. Lockhart transitioned to consulting and relocated to Paris. While working in Africa and witnessing the plight of women and girls, she realized her skills could be put to greater use. She did something about it.
Mr. Lyash is a 40-year veteran of the power industry with experience in design, construction and operation of power systems. He served as President & CEO of the Tennessee Valley Authority (TVA), President & CEO and Director of Ontario Power Generation, and President of Chicago Bridge & Iron Power. Earlier, he held executive and technical roles with Carolina Power & Light (CP&L) and successor companies Progress Energy and Duke Energy, including President & CEO of Progress Energy Florida and Duke Energy's Executive Vice President of Energy Supply. Before joining CP&L, he worked for the U.S. Nuclear Regulatory Commission (NRC) and received the NRC’s Meritorious Service Award.
Mr. Lyash served as Chairman of the Electric Power Research Institute, the Nuclear Energy Institute, the World Association of Nuclear Operators Atlanta Center and the Institute of Nuclear Power Operations. He currently serves as an independent director on the Boards of Dominion Energy Inc. and AECON Group Inc., an advisor to the Japanese Nuclear Safety Institute, and a trustee of Drexel University. He previously served on the Boards of Granite Construction Inc., Ontario Power Generation and Progress Energy Florida.
Mr. Lyash earned a bachelor's degree in mechanical engineering from Drexel University and received the Drexel University Distinguished Alumnus Award. He has held a Senior Reactor Operator License from the U.S. NRC and is a graduate of the Duke University Fuqua School of Business Advanced Management Program, the University of Toronto Rotman School of Management Institute of Corporate Directors Program (ICD.D), and the National Association of Corporate Directors Certification Program (NACD.D).
Mr. Marion’s experience as the Chief Editor of The Triangle from 1971 to 1972 directly led to a career in publishing. He was a writer, editor and publisher of business and technology magazines, books, research reports and websites for more than 40 years. He worked for BusinessWeek, Forbes, Harvard Business Review, Electronics, Electronics Design, Institutional Investor, Computerworld, CIO and several other publications. As an entrepreneur, he launched Triangle Publishing Services Co. and grew it into a multimillion-dollar custom-publishing company before his retirement in 2019.
Currently, Mr. Marion is a member and former chair of the Triangle Alumni Advisory Board supporting The Triangle. He launched and funded an endowment to provide The Triangle with financial support in perpetuity. Mr. Marion also launched a scholarship for The Triangle editors-in-chief. In addition, Mr. Marion is an author, webcast moderator, support group co-facilitator and member of the Patient Advisory Board of the Chronic Lymphocytic Leukemia (CLL) Society.
Mr. Srinivasan is a seasoned healthcare leader with over 25 years of experience in clinical diagnostics and medical devices. Mr. Srinivasan specializes in scaling disruptive technologies from concept to commercialization.
Mr. Srinivasan is currently serving as the Executive Chair at infinitusbio.AI, a pharmatech startup with a vision to accelerate cures for diseases that lack one today. As the former President and CEO of Truvian Health, a San Diego based venture capital-backed startup, Mr. Srinivasan was instrumental in delivering the company’s mission to decentralize blood testing. Under his leadership, Truvian advanced its flagship benchtop platform, which integrates chemistry, immunoassay and hematology testing into a single, lab-accurate solution designed for retail clinics and physician offices. The company received FDA approval for the platform in 2025. Prior to Truvian, Mr. Srinivasan held executive roles at Abbott Laboratories, GenMark Diagnostics and Danaher (Beckman Coulter), and Qiagen.
Mr. Srinivasan holds a Master of Science in Biomedical Engineering from Drexel University, and an MBA from Northwestern’s Kellogg School of Management.
Mr. Srinivasan sits on the Industry Advisory Board at the School of Biomedical Engineering, Science and Health Systems at his alma mater Drexel University and serves as the founding member of the Industry Advisory Board at Colorado State University. His journey to democratize health care has been featured in Newsweek, The Wall Street Journal and several podcasts over the years.
Ms. Trotman is President and CEO of Electro Soft, Inc., a second-generation family electronics contract manufacturing company based in Montgomeryville, Pennsylvania. Since taking the helm during the COVID-19 pandemic, Ms. Trotman has navigated unprecedented challenges while positioning the company as a partner in defense, aviation, rail and transit markets. Electro Soft specializes in wire harnesses, cable assemblies, PCBs and military electronics for critical applications.
Before leading the family business founded in 1986, Ms. Trotman built her expertise through corporate roles at Fortune 500 companies including Honeywell, Gap and IKEA. She earned her Bachelor of Science in Business Logistics from Penn State University and completed her MBA at Drexel University in 2015. While running her e-commerce company, she recognized the shift in sales and marketing from in-person to online engagement. This insight led her to join the family business, where she helped pivot its strategy and break a flat revenue streak, ultimately buying her parents out in 2020.
Ms. Trotman was named the 2024 EY Entrepreneur of the Year for Greater Philadelphia. An advocate for American manufacturing, she authored the #1 Amazon bestseller “Dark, Dirty, Dangerous: Building the Vibrant Future of Manufacturing” and serves as past Co-Chair of the Southeastern Pennsylvania Manufacturing Alliance (SEPMA).
Ms. Trotman maintains ties to Drexel, previously serving as President of the Executive MBA Alumni Board and on the Alumni Board of Governors. She currently serves on the LeBow Marketing Department Advisory Board and the President’s Leadership Council. Her community commitment includes board service with the Museum of the American Revolution, Free Library of Philadelphia Foundation and African Women’s Entrepreneurship Cooperative.
Mr. Valentine has been a scientist, inventor, salesman, entrepreneur and philanthropist.
He grew up among writers, artists and musicians with family friends like Asa Randolph, W.E.B. DuBois and Bayard Rustin. As a teen, he was the Chief Engineer for the local radio station and a mainframe computer operator at a nearby college. That early promise was recognized by Lincoln University in Pennsylvania, where he studied physics under renowned scientist and university president Dr. Herman Branson, who discovered the Alpha Helix protein. President Branson created an engineering program with Drexel University where top students were awarded a degree from Lincoln and a degree from Drexel. At Lincoln, he co-authored with Gil Scott-Heron “The Revolution will not be Televised.” Those lyrics are in the Library of Congress National Recording Registry, considered a cornerstone of early hip-hop and social justice anthems.
At Drexel, his co-op was a U.S. Navy flight mission where he ran his computer programs in flight. After graduation he was recruited by Eastman Kodak as a principal research scientist where he created integrated circuits. Research programs that repositioned the traditional passive image processor to actively processing images were the first concepts of what is today the ubiquitous digital camera. He was engineering lead on imaging projects such as the first electronic medical record system (PA/PACS) which won the R&D100 award for industrial design. He hopes sharing his story will inspire “skinny small-town kids” to pursue careers in science.
Ms. Weiss is a seasoned clinical research professional with a diverse career spanning over 30 years in academic research, large and small pharmaceutical organizations, and nonprofit global health research.
She began her career at Hahnemann Hospital, followed by the Hospital of the University of Pennsylvania before transitioning to leadership roles at Merck & Co., Inc. and Shire Pharmaceuticals. She currently serves as Chief Operating Officer at the Gates Medical Research Institute, where she oversees strategic and operational initiatives to advance the organization's mission. In addition, Ms. Weiss has been an adjunct professor at Temple University for more than 20 years, teaching a graduate course in good clinical practices (GCPs). Ms. Weiss earned her Master of Science in Nursing from the University of Pennsylvania and her Bachelor of Science in Nursing from Drexel University.